Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection

Journal of Chromatography B: Biomedical Applications

Volumn 705, Issue 1, 1998, Pages 159-164

  Sparreboom, Alex ^a   De Bruijn, Peter ^a   Nooter, Kees ^a   Loos, Walter J ^a   Stoter, Gerrit ^a   Verweij, Jaap ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Paclitaxel

Indexed keywords

ACETONITRILE; ALIZAPRIDE; AMMONIUM HYDROXIDE; BUTYL CHLORIDE; CODEINE; DEXAMETHASONE; DOCETAXEL; LORAZEPAM; METHANOL; METOCLOPRAMIDE; MORPHINE; PACLITAXEL; PARACETAMOL; PAROXETINE; RANITIDINE; REAGENT; SOLVENT; TETRAHYDROFURAN; UNCLASSIFIED DRUG; WATER;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG INFUSION; EXTRACTION; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; PATIENT; PLASMA; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INJECTIONS, INTRAVENOUS; PACLITAXEL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0032559438     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(97)00502-1     Document Type: Article

References (26)

1. Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. J. Am. Chem. Soc. 93:1971;2325.
2. Schiff P.B., Fant J., Horwitz S.B. Nature. 277:1979;665.
3. Schiff P.B., Horwitz S.B. Proc. Natl. Acad. Sci. U.S.A. 77:1980;1561.
4. Verweij J., Clavel M., Chevalier B. Ann. Oncol. 5:1994;495.
5. Hamel E., Lin C.M., Johns D.G. Cancer Treat. Rep. 66:1982;1381.
6. Lin C.M., Jiang Y.Q., Chaudhary A.G., Rimoldi J.M., Kingston D.G., Hamel E. Cancer Chemother. Pharmacol. 38:1996;136.
7. Grothaus P.G., Raybould T.J.G., Bignami G.S., Lazo G.B., Byrnes J.B. J. Immunol. Methods. 158:1993;5.
8. Leu J.-G., Chen B.-X., Schiff P.B., Erlanger B.F. Cancer Res. 53:1993;1388.
9. Hempel G., Lehmkuhl D., Krumpelmann S., Blaschke G., Boos J. J. Chromatogr. A. 745:1996;173.
10. Wiernik P.H., Schwartz E.L., Strauman J.J., Dutcher J.P., Lipton R.B., Paietta E. Cancer Res. 47:1987;2486.
11. Grem J.L., Tutsch K.D., Simon K.J., Alberti D.B., Wilson K.V., Tormey D.G., Swaminathan S., Trump D.L. Cancer Treat. Rep. 71:1987;1179.
12. Longnecker S.M., Donehower R.C., Cates A.E., Chen T., Brundrett R.B., Grochow L.B., Ettinger D.S., Colvin M. Cancer Treat. Rep. 71:1987;53.
13. Song D., Au J.-L. J. Chromatogr. B. 663:1995;337.
14. Rizzo J., Riley C., Von Hoff D.D., Kuhn J., Phillips J., Brown T. J. Pharm. Biomed. Anal. 8:1991;159.
15. Willey T.A., Bekos E.J., Gaver R.C., Duncan G.F., Tay L.K., Beijnen J.H., Farmen R.H. J. Chromatogr. 621:1993;231.
16. Huizing M.T., Sparreboom A., Rosing H., Van Tellingen O., Pinedo H.M., Beijnen J.H. J. Chromatogr. B. 674:1995;261.
17. Jamis-Dow C.A., Klecker R.W., Sarosy G., Reed E., Collins J.M. Cancer Chemother. Pharmacol. 33:1993;48.
18. H. Mase, M. Hiraoka, A. Suzuki, H. Nakanomyo, Yakugaku Zasshi, 114 (1994) 351 (Japanese).
19. Ohtsu T., Sasahi Y., Tamura T., Miyata Y., Nakanomyo H., Nishiwaki Y., Saijo N. Clin. Cancer Res. 1:1995;599.
20. El-Yazigi A., Yusuf A. Ther. Drug Monit. 17:1995;511.
21. M.T. Huizing, Thesis, Utrecht University, Utrecht, 1996, pp. 59-69.
22. Loos W.J., Verweij J., Nooter K., Stoter G., Sparreboom A. J. Chromatogr. B. 693:1997;437.
23. Sparreboom A., Huizing M.T., Boesen J.J.B., Nooijen W.J., Van Tellingen O., Beijnen J.H. Cancer Chemother. Pharmacol. 36:1995;299.
24. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A., Layloff T., Viswanathan C.T., Cook C.E., McDowall R.D., Pittman K.A., Spector S. J. Pharm. Sci. 81:1992;309.
25. Proost J.H., Meijer D.K.F. Comp. Biol. Med. 22:1992;155.
26. Huizing M.T., Keung A.C.F., Rosing H., Van der Kuij V., Ten Bokkel Huinink W.W., Mandjes I.M., Dubbelman A.C., Pinedo H.M., Beijnen J.H. J. Clin. Oncol. 11:1993;2127.